To summarize, we demonstrated that SQLE overexpression is independently associated with an unfavorable outcome in breast cancer, even when taking into consideration classical clinical and pathological variables such as age, tumor size, nodal status, grade, ER, and Her2 status. This evidence concerns the gene ESR1 and breast carcinoma.